Omega Diagnostics(DE:RVKA)
€0.010.00 (0.00%)
DE:RVKA
Omega Diagnostics financials statements
€0.01
At close:0.00 (0.00%)
Omega Diagnostics (RVKA) Income Statement
0 Followers
Omega Diagnostics Income Statement
Last quarter (Q2 2026), Omega Diagnostics's total revenue was £2.36M, a decrease of 42.94% from the same quarter last year. In Q2, Omega Diagnostics's net income was £-796.00K. See Omega Diagnostics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| £ 6.97M | £ 8.33M | £ 9.77M | £ 7.55M | £ 8.54M | |
| £ 4.28M | £ 5.00M | £ 6.05M | £ 3.17M | £ 4.75M | |
| £ 5.32M | £ 5.64M | £ 6.58M | £ 5.95M | £ 5.33M | |
| Depreciation and Amortization | £ 653.00K | £ 615.00K | £ 650.00K | £ 591.00K | £ 1.29M |
| £ -392.00K | £ 2.20M | £ -73.00K | £ -2.65M | £ 360.00K | |
| £ -1.04M | £ -640.00K | £ -535.00K | £ -2.78M | £ -582.00K | |
| £ -3.38M | £ 2.21M | £ -210.00K | £ -473.00K | £ -358.00K | |
| £ -4.42M | £ 1.57M | £ -745.00K | £ -3.25M | £ -950.00K | |
| £ -5.83M | £ 1.57M | £ -328.00K | £ -3.86M | £ -11.33M | |
| Per Share Metrics | |||||
| Basic EPS | £ -0.02 | £ 0.01 | £ -0.00 | £ -0.02 | £ -0.06 |
| Diluted EPS | £ -0.02 | £ 0.01 | £ -0.00 | £ -0.02 | £ -0.06 |
| Weighted Average Shares Outstanding | 237.95M | 238.27M | 237.73M | 231.26M | 182.64M |
| Weighted Average Shares Outstanding (Diluted) | 237.95M | 238.27M | 238.10M | 231.26M | 182.64M |
Currency in GBP
